| Literature DB >> 29963858 |
Juanjuan Yang1, Qiao Jiang2, Lin He1, Pengfei Zhan2, Qing Liu2, Shaoli Liu2, Meifang Fu2, Jianbing Liu2, Can Li1, Baoquan Ding2,3.
Abstract
DNA nanostructures are promising biomaterials capable of arranging multiple functional components with nanometer precision. Here, a double-bundle DNA tetrahedron is rationally designed to integrate with antisense oligonucleotides silencing proto-oncogene c-raf and nuclear targeting peptides. The functionalized DNA tetrahedron can be internalized by A549 cells and assists the delivery of antisense oligonucleotides toward the nucleus to increase the chance to downregulate target mRNA in nucleus and cytoplasm. Antisense strands released from the tetrahedron in response to the intracellular reducing environment can inhibit cell proliferation at a low concentration without transfection reagent. Finally, efficient knockdown of c-raf gene is observed, which verified our design. This designer DNA-based nanocarrier system will open a new avenue for efficient delivery of nucleic acid drugs.Entities:
Keywords: antisense oligonucleotides; cancer therapy; double-bundle DNA tetrahedron; drug delivery; self-assembly
Mesh:
Substances:
Year: 2018 PMID: 29963858 DOI: 10.1021/acsami.8b07889
Source DB: PubMed Journal: ACS Appl Mater Interfaces ISSN: 1944-8244 Impact factor: 9.229